4//SEC Filing
Ahrens Brenton Karl 4
Accession 0001209191-22-039711
CIK 0001659323other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 9:00 PM ET
Size
5.5 KB
Accession
0001209191-22-039711
Insider Transaction Report
Form 4
Ahrens Brenton Karl
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-25+113,276→ 113,276 totalExercise: $0.20Exp: 2032-06-24→ Ordinary Shares (113,276 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on April 1, 2023
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001322927
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 9:00 PM ET
- Size
- 5.5 KB